Douglas Chen
About Douglas Chen
Douglas Chen is the Associate Director of US Finance Eliquis at Bristol Myers Squibb, with extensive experience in various finance roles spanning over two decades.
Company
Douglas Chen is currently employed at Bristol Myers Squibb, a global biopharmaceutical company. Bristol Myers Squibb is known for developing and manufacturing medications in various therapeutic areas, including oncology, cardiovascular, and immunology. Chen has been with the company in different capacities for over two decades, contributing significantly to its financial operations.
Title
Douglas Chen holds the position of Associate Director, US Finance Eliquis at Bristol Myers Squibb. In this role, he is responsible for the financial management of Eliquis, a medication used to treat and prevent blood clots. His position involves overseeing budgeting, financial reporting, and strategic financial planning specific to Eliquis in the US market.
Education and Expertise
Douglas Chen earned his Bachelor of Science (BS) degree from Penn State University, where he studied from 1987 to 1991. His education provided a strong foundation for his extensive career in finance, particularly in the pharmaceutical industry. Chen’s expertise spans budgeting, expense management, strategic planning, and financial reporting.
Background
Douglas Chen has a diverse background in finance with significant experience in the pharmaceutical sector. He began his career at Prudential Financial, where he worked as a Financial Analyst focusing on AARP Operations for six years. He then moved on to The Hartford, where he specialized in Budget and Expense Management. Chen joined Bristol Myers Squibb in 1998 and has held various roles, including Principal Financial Analyst, Finance Manager for Asia Pacific, and multiple Associate Director positions in different finance functions.
Professional Experience at Bristol Myers Squibb
Douglas Chen's career at Bristol Myers Squibb spans several key roles. He started as Principal Financial Analyst, Intercontinental Region before becoming Finance Manager, Asia Pacific. He then moved into the role of Associate Director, US Finance, followed by positions in R&D Finance, Enterprise Services Finance, and IT Finance Lead. Currently, he serves as the Associate Director, US Finance Eliquis, where he manages the financial operations for one of the company’s critical products.